Detection of Major Mutations in CFTR, SERPINA1, HFE Genes in Benign Unconjugated Hyperbilirubinemia Phenotype
The aim of the study was to search for the associations of benign unconjugated hyperbilirubinemia phenotype with rs1799945 (H63D), rs1800562 (C282Y), rs1800730 (S65C) mutations of HFE gene, rs113993960 (ΔF508) of CFTR gene, rs28929474 (PIZ), rs17580 (PIS) mutations of SERPINA1 gene.
Material and Methods. The study design is case–control. The group with Gilbert’s syndrome (GS) phenotype (n=414; mean age — 36.7±15.9 years; 49.8% men) was formed by gastroenterologists, and included the individuals with unconjugated hyperbilirubinemia who underwent a standard clinical examination. The individuals with known causes of unconjugated hyperbilirubinemia were excluded from the group. The control group (n=429; mean age — 38.5±14.3 years; 52.2% men) was a random sampling from DNA banks of MONICA project participants, the screening of young people aged 25–44 and a one-time study of schoolchildren in Novosibirsk (Russia). DNA was isolated by phenol-chloroform extraction or by the express method (PROBA-RAPID-GENETIKA; DNA-Technology, Moscow, Russia) from venous blood. Genotyping of groups by nucleotide sequence rs1799945 (H63D), rs1800562 (C282Y), rs1800730 (S65C) of HFE gene, rs113993960 (ΔF508) of CFTR gene, rs28929474 (PIZ), rs17580 (PIS) of SERPINA1 gene was performed by polymerase chain reaction followed by the analysis of fragment length polymorphism on a polyacrylamide gel.
Results. According to the genotypes and alleles of the variants rs1799945 (H63D), rs1800562 (C282Y), rs1800730 (S65C) of HFE gene, rs113993960 (ΔF508) of CFTR gene, rs28929474 (PIZ), rs17580 (PIS) of SERPINA1 gene, no statistically significant differences were found between the GS group and the control group (p>0.05).
Conclusion. Nucleotide sequence variants rs1799945 (H63D), rs1800562 (C282Y), rs1800730 (S65C) of HFE gene, rs113993960 (ΔF508) of CFTR gene, rs28929474 (PIZ), rs17580 (PIS) of SERPINA1 gene, or their combinations with rs3064744 of UGT1A1 gene were found to have no association with GS.
- King D., Armstrong M.J. Overview of Gilbert’s syndrome. Drug Ther Bull 2019; 57(2): 27–31, https://doi.org/10.1136/dtb.2018.000028.
- Sikorska K., Romanowski T., Stalke P., Jaskiewicz K., Bielawski K.P. Coexistence of HFE and rare UGT1A1 genes mutations in patients with iron overload related liver injury. Adv Med Sci 2010; 55(1): 108–110, https://doi.org/10.2478/v10039-010-0003-x.
- Ivanova A.A., Gurazheva A.A., Mel’nikova E.S., Maksimov V.N., Nemcova E.G. Study of molecular genetic markers of Gilbert’s syndrome. Bulletin of Siberian Medicine 2023; 22(2): 39–45, https://doi.org/10.20538/1682-0363-2023-2-39-45.
- HFE homeostatic iron regulator [Homo sapiens (human)]. URL: https://www.ncbi.nlm.nih.gov/gene/3077.
- Katsarou M.S., Papasavva M., Latsi R., Drakoulis N. Hemochromatosis: hereditary hemochromatosis and HFE gene. Vitam Horm 2019; 110: 201–222, https://doi.org/10.1016/bs.vh.2019.01.010.
- CFTR CF transmembrane conductance regulator [Homo sapiens (human)]. URL: https://www.ncbi.nlm.nih.gov/gene/1080.
- Shteinberg M., Haq I.J., Polineni D., Davies J.C. Cystic fibrosis. Lancet 2021; 397(10290): 2195–2211, https://doi.org/10.1016/S0140-6736(20)32542-3.
- Miller A.C., Comellas A.P., Hornick D.B., Stoltz D.A., Cavanaugh J.E., Gerke A.K., Welsh M.J., Zabner J., Polgreen P.M. Cystic fibrosis carriers are at increased risk for a wide range of cystic fibrosis-related conditions. Proc Natl Acad Sci U S A 2020; 117(3): 1621–1627, https://doi.org/10.1073/pnas.1914912117.
- SERPINA1 serpin family A member 1 [Homo sapiens (human)]. URL: https://www.ncbi.nlm.nih.gov/gene/5265.
- Nachtegael C., Gravel B., Dillen A., Smits G., Nowé A., Papadimitriou S., Lenaerts T. Scaling up oligogenic diseases research with OLIDA: the Oligogenic Diseases Database. Database (Oxford) 2022; 2022: baac023, https://doi.org/10.1093/database/baac023.
- Ramos M.D., Trujillano D., Olivar R., Sotillo F., Ossowski S., Manzanares J., Costa J., Gartner S., Oliva C., Quintana E., Gonzalez M.I., Vazquez C., Estivill X., Casals T. Extensive sequence analysis of CFTR, SCNN1A, SCNN1B, SCNN1G and SERPINA1 suggests an oligogenic basis for cystic fibrosis-like phenotypes. Clin Genet 2014; 86(1): 91–95, https://doi.org/10.1111/cge.12234.
- Stanke F., Janciauskiene S., Tamm S., Wrenger S., Raddatz E.L., Jonigk D., Braubach P. Effect of alpha-1 antitrypsin on CFTR levels in primary human airway epithelial cells grown at the air-liquid-interface. Molecules 2021; 26(9): 2639, https://doi.org/10.3390/molecules26092639.
- Rohlfs E.M., Shaheen N.J., Silverman L.M. Is the hemochromatosis gene a modifier locus for cystic fibrosis? Genet Test 1998; 2(1): 85–88, https://doi.org/10.1089/gte.1998.2.85.